Delivery Order SPE2DB20D9637-SPE2DB24FC9PB
Award Date
7/30/24
Potential Completion Date
8/20/24
Potential Value
$17K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order with a potential value of $11,523.20 awarded by the Defense Logistics Agency Troop Support Medical to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business organization. The contract is for the delivery of 1,000 unit vials of the pharmaceutical product KCENTRA by October 20, 2022. DMS Pharmaceutical Group Inc. is the prime contractor and there is no set-aside designation for this award. The contract is issued under DMS Pharmaceutical...
This contract was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $20,592.96, is for the delivery of 1,000 unit vials of the drug KCENTRA. The contract is a firm fixed-price delivery order, with an ultimate completion date of June 17, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA, valued at up to...
This is a federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, for the delivery of 1,000 unit vials of the biologic medication KCENTRA. The contract has a firm fixed-price, delivery order type, with a ceiling value of $58,453.12 and a period of performance through May 13, 2024. The contract is not associated with a set-aside...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 1,000 unit vials of the pharmaceutical product KCENTRA. The order is valued at $35,045.12 and has a completion date of January 26, 2024. DMS Pharmaceutical Group holds multiple contracts and indefinite delivery vehicles with DLA to supply a wide range of pharmaceutical and medical products to support military treatment facilities...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of 1,000 unit vials of the drug KCENTRA. The order, valued at $72,075.36, has an ultimate completion date of June 21, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which allows the agency to issue delivery orders for a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 1,000 unit vials of the medication KCENTRA, with a ceiling value of $3,198.08 and a completion date of April 3, 2025. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of...
This federal contract award is for a delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the supply of 1,000 unit vials of the medication Kcentra, with a total ceiling value of $58,140.00. The contract is a firm fixed-price delivery order with no set-aside designation, and it has an ultimate completion date of August 22, 2024. DMS Pharmaceutical Group Inc. holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $16,020.80 firm fixed-price contract is for the delivery of 1,000 unit vials of the pharmaceutical product KCENTRA, with a completion date of June 6, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract, valued at $20,465.28, is for the delivery of 1,000 unit vials of the pharmaceutical product KCENTRA. The delivery order has an ultimate completion date of July 7, 2025. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing direct distribution of prescription drugs and pharmacy...
This is a delivery order issued by the Defense Logistics Agency (DLA) under the Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $17,297.60 firm fixed-price contract is for the delivery of KCENTRA 500UNIT 1S, a pharmaceutical product, with a completion date of July 12, 2024. The contract is not set-aside and is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS...